AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 276.3 |
Market Cap | 79.24B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 10.55 |
PE Ratio (ttm) | 27 |
Forward PE | n/a |
Analyst | Buy |
Ask | 290.7 |
Volume | 1,572,831 |
Avg. Volume (20D) | 2,062,370 |
Open | 282.00 |
Previous Close | 282.45 |
Day's Range | 280.85 - 285.68 |
52-Week Range | 262.03 - 370.83 |
Beta | undefined |
About CI
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dent...
Analyst Forecast
According to 23 analyst ratings, the average rating for CI stock is "Buy." The 12-month stock price forecast is $400, which is an increase of 40.41% from the latest price.
Next Earnings Release
Analysts project revenue of $63.03B, reflecting a 23.23% YoY growth and earnings per share of 7.82, making a 15.17% increase YoY.
4 weeks ago · https://thefly.com
Barclays fact-checked Trump comments on pharmacy benefit managersBarclays analyst Andrew Mok said that while the existential risk to pharmacy benefit managers is low, President-elect Trump's comments yesterday point to additional headline risk and greater support f...